1 results match your criteria: "f Department of Quantitative Clinical Pharmacology[Affiliation]"
Pharmacokinetics and metabolism of [C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers.
Xenobiotica
August 2017
f Department of Quantitative Clinical Pharmacology, UCB Pharma , Braine l'Alleud, , Belgium.
1. This phase-I study (NCT02240290) was designed to investigate the human absorption, disposition and mass balance of C-tozadenant, a novel A2a receptor antagonist in clinical development for Parkinson s disease. 2.
View Article and Find Full Text PDF